Cargando…

GPRC5D as a promising therapeutic target in EGFR-wild and immuno-cold non-small cell lung cancer

Detalles Bibliográficos
Autores principales:	Mei, Jie, Cai, Yun, Jiang, Guanyu, He, Zhao, Wang, Ruixin, Song, Chenghu, Wan, Yuan, Mao, Wenjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424388/ https://www.ncbi.nlm.nih.gov/pubmed/37574551 http://dx.doi.org/10.1186/s12967-023-04415-w

Ejemplares similares

SECTM1 is upregulated in immuno-hot tumors and predicts immunotherapeutic efficacy in multiple cancers
por: Mei, Jie, et al.
Publicado: (2023)

SECTM1 is upregulated in immuno-hot tumors and predicts immunotherapeutic efficacy in multiple cancers
por: Mei, Jie, et al.
Publicado: (2023)

Cancer vaccines as promising immuno-therapeutics: platforms and current progress
por: Liu, Jian, et al.
Publicado: (2022)

The role of lipid metabolic reprogramming in tumor microenvironment
por: Yang, Kai, et al.
Publicado: (2023)

EGFR phosphorylates and inhibits lung tumor suppressor GPRC5A in lung cancer
por: Lin, Xiaofeng, et al.
Publicado: (2014)

HLA class II molecule HLA-DRA identifies immuno-hot tumors and predicts the therapeutic response to anti-PD-1 immunotherapy in NSCLC
por: Mei, Jie, et al.
Publicado: (2022)

circGprc5a Promoted Bladder Oncogenesis and Metastasis through Gprc5a-Targeting Peptide
por: Gu, Chaohui, et al.
Publicado: (2018)

The emerging roles of GPRC5A in diseases
por: Zhou, Honglei, et al.
Publicado: (2014)

Physical exercise reverses immuno-cold tumor microenvironment via inhibiting SQLE in non-small cell lung cancer
por: Luo, Zhi-Wen, et al.
Publicado: (2023)

Computationally identified novel agonists for GPRC6A
por: Pi, Min, et al.
Publicado: (2018)

GPRC5A: An Emerging Biomarker in Human Cancer
por: Jiang, Xiaoxia, et al.
Publicado: (2018)

Identification of Immuno-Targeted Combination Therapies Using Explanatory Subgroup Discovery for Cancer Patients with EGFR Wild-Type Gene
por: Kholod, Olha, et al.
Publicado: (2022)

Impaired Osteoblast Function in GPRC6A Null Mice
por: Pi, Min, et al.
Publicado: (2010)

GPRC6A: Jack of all metabolism (or master of none)
por: Pi, Min, et al.
Publicado: (2016)

GPRC5B protects osteoarthritis by regulation of autophagy signaling
por: He, Liang, et al.
Publicado: (2023)

Role of GPRC6A in Regulating Hepatic Energy Metabolism in Mice
por: Pi, Min, et al.
Publicado: (2020)

GPRC6A Mediates Glucose and Amino Acid Homeostasis in Mice
por: He, Yumin, et al.
Publicado: (2022)

EGFR endocytosis is a novel therapeutic target in lung cancer with wild-type EGFR
por: Jo, Ukhyun, et al.
Publicado: (2014)

The multi-omics analysis identifies a novel cuproptosis-anoikis-related gene signature in prognosis and immune infiltration characterization of lung adenocarcinoma
por: Jiang, Guanyu, et al.
Publicado: (2023)

Clathrin‐mediated EGFR endocytosis as a potential therapeutic strategy for overcoming primary resistance of EGFR TKI in wild‐type EGFR non‐small cell lung cancer
por: Kim, Boyeon, et al.
Publicado: (2020)

The promise of Immuno-oncology: implications for defining the value of cancer treatment
por: Kaufman, Howard L., et al.
Publicado: (2019)

GPRC6A Null Mice Exhibit Osteopenia, Feminization and Metabolic Syndrome
por: Pi, Min, et al.
Publicado: (2008)

Humanized GPRC6A(KGKY) is a gain-of-function polymorphism in mice
por: Pi, Min, et al.
Publicado: (2020)

RhoA/C inhibits proliferation by inducing the synthesis of GPRC5A
por: Richter, Lukas, et al.
Publicado: (2020)

Undercarboxylated osteocalcin inhibits the early differentiation of osteoclast mediated by Gprc6a
por: Wang, Hailong, et al.
Publicado: (2021)

Explaining Divergent Observations Regarding Osteocalcin/GPRC6A Endocrine Signaling
por: Pi, Min, et al.
Publicado: (2021)

Small molecular fluorescence dyes for immuno cell analysis
por: Jiang, Janine, et al.
Publicado: (2021)

Establishment and validation of nomograms for predicting survival of lung invasive adenocarcinoma based on the level of pathological differentiation: a SEER cohort-based analysis
por: Wang, Xiaokun, et al.
Publicado: (2023)

Osteocalcin-GPRC6A: An update of its clinical and biological multi-organic interactions
por: Diaz-Franco, Martha Cristina, et al.
Publicado: (2019)

miR-342 inhibits glioma cell proliferation by targeting GPRC5A
por: Wang, Jianjiao, et al.
Publicado: (2019)

Metabolic and skeletal homeostasis are maintained in full locus GPRC6A knockout mice
por: Jørgensen, Christinna V., et al.
Publicado: (2019)

Osteocalcin Alleviates Nonalcoholic Fatty Liver Disease in Mice through GPRC6A
por: Zhang, Mingliang, et al.
Publicado: (2021)

Orphan G-Protein Coupled Receptor GPRC5B Is Critical for Lymphatic Development
por: Xu, Wenjing, et al.
Publicado: (2022)

Hyaluronic acid–GPRC5C signalling promotes dormancy in haematopoietic stem cells
por: Zhang, Yu Wei, et al.
Publicado: (2022)

Aquaporin-4 and GPRC5B: old and new players in controlling brain oedema
por: Passchier, Emma M J, et al.
Publicado: (2023)

Harnessing αβ T cell receptor mechanobiology to achieve the promise of immuno-oncology
por: Reinherz, Ellis L., et al.
Publicado: (2023)

Profile: ImmunoCellular Therapeutics Ltd.
por: Yu, John S.
Publicado: (2012)

Statin shapes inflamed tumor microenvironment and enhances immune checkpoint blockade in non–small cell lung cancer
por: Mao, Wenjun, et al.
Publicado: (2022)

Osteocalcin Promotes β-Cell Proliferation During Development and Adulthood Through Gprc6a
por: Wei, Jianwen, et al.
Publicado: (2014)

GPRC6a is not Required for the Effects of a High-Protein Diet on Body Weight in Mice
por: Kinsey-Jones, James S, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_g1lbockdajohrj23umcnbg2n83